GENEVA, Aug. 21 -- BAYLOR COLLEGE OF MEDICINE filed a patent application (US2026/015483) for “NOREPINEPHRINE SIGNALING ACTIVATORS TO IMPROVE SLEEP AND DELAY ALZHEIMER'S DISEASE PROGRESSION”. With publication no. WO/2026/174298, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/138
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....